Anna Rosenblatt

570 citations
6 papers · 252 indexed · h-index 4
Topics
COVID-19 Clinical Research Studies (3 papers)Long-Term Effects of COVID-19 (3 papers)Atrial Fibrillation Management and Outcomes (3 papers)
Partner nations
United StatesPoland

In The Last Decade

Anna Rosenblatt

4 papers receiving 249 citations

Peers

Anna Rosenblatt
Comparison fields: 5 of 54
  • Infectious Diseases 174
  • Neurology 100
  • Oncology 61
  • Cardiology and Cardiovascular Medicine 57
  • Epidemiology 31
Replace Anjali Rao with:
Anjali Rao United States
Spencer Carter United States
Jason Walchok United States
Evangelia Koutli Greece
Prabal Chourasia United States
Haozhe Sun United States
Rehan Saeed United States
Hüseyin Mutlu Türkiye
Joshua Lang United States
Karthik Gangu United States
Anna Rosenblatt relative to Anjali Rao United States Anjali Rao's profile →
Citations per field
00.5×1.5×
Anjali Rao · 1×
Citations per year

Countries citing papers authored by Anna Rosenblatt

Since Specialization
Citations

This map shows the geographic impact of Anna Rosenblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rosenblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rosenblatt more than expected).

Fields of papers citing papers by Anna Rosenblatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rosenblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rosenblatt. The network helps show where Anna Rosenblatt may publish in the future.

Co-authorship network of co-authors of Anna Rosenblatt

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rosenblatt. A scholar is included among the top collaborators of Anna Rosenblatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rosenblatt. Anna Rosenblatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 0
2 0
3 50
4 16
5 183
6 3

About Anna Rosenblatt

Anna Rosenblatt is a scholar working on Neurology, Anesthesiology and Pain Medicine and Infectious Diseases, having authored 6 papers that have together received 252 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). The work is most often cited by research in Infectious Diseases (174 citations), Neurology (100 citations) and Internal Medicine (11 citations). Anna Rosenblatt has collaborated with scholars based in United States and Poland. Frequent co-authors include Anjali Rao, Sandeep R. Das, Nicholas Hendren, Colby Ayers, James A. de Lemos, Wally Omar, Rohan Khera, Mark H. Drazner, Justin L. Grodin and Ian J. Neeland. Their work appears in journals such as Circulation, Journal of the American Heart Association and Heart Rhythm.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026